Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29195601 | 0.91 | MMP1 (0.43) | MMP1MMP3MMP8GAAMAPT | |
| SCHEMBL329843 | 0.83 | MMP1 (0.50) | MMP1MMP3MMP8GAAMAPT | |
| SCHEMBL6882336 | 0.83 | MMP1 (0.38) | MMP1MMP3MMP8GAAMAPT | |
| Hydrochloric Acid SCHEMBL11081547 | 0.81 | MMP1 (0.48) | MMP1MMP3MMP8GAAMAPT | |
| SCHEMBL1246279 | 0.79 | MMP1 (0.46) | MMP1MMP3MMP8GAAMAPT | |
| SCHEMBL7455288 | 0.79 | MMP1 (0.46) | MMP1MMP3MMP8GAAMAPT | |
| SCHEMBL3392230 | 0.78 | FDPS (0.33) | MMP1MMP3MMP8MAPTSMN1; SMN2 | |
| SCHEMBL15536892 | 0.78 | FDPS (0.33) | MMP1MMP3MMP8MAPTSMN1; SMN2 | |
| SCHEMBL654555 | 0.78 | — | — | |
| SCHEMBL1276983 | 0.77 | MAPT (0.46) | MMP1MMP3MMP8GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114643075-B | Catalyst for synthesizing alkylene carbonate, and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-29 | — | — | CN | disclosed |
| US-8624029-B2 | Lipidated imidazoquinoline derivatives | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2014-01-07 | — | — | US | disclosed |
| US-7767842-B2 | Class of γδ T cells activators and use thereof | INNATE PHARMA SA (FR) | 2010-08-03 | — | — | US | disclosed |
| EP-1328610-B1 | PHOSPHATE FLUOROSURFACTANTS FOR USE IN CARBON DIOXIDE | UNIV NORTH CAROLINA (US) | 2008-07-02 | — | — | EP | disclosed |
| EP-1328610-B1 | PHOSPHATE FLUOROSURFACTANTS FOR USE IN CARBON DIOXIDE | UNIV NORTH CAROLINA (US) | 2008-07-02 | — | — | EP | disclosed |
| US-20070249565-A1 | Class of Gamma Delta T Cells Activators and Use Thereof | INNATE PHARMA S.A. (FR) | 2007-10-25 | — | — | US | disclosed |
| US-7122060-B2 | Phosphate fluorosurfactants for use in carbon dioxide | THE UNIVERSITY OF NORTH CAROLINA (US) | 2006-10-17 | — | — | US | disclosed |
| EP-1689758-A2 | NEW CLASS OF GAMMA DELTA T CELLS ACTIVATORS AND USE THEREOF | Innate Pharma (FR) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005054258-A2 | NEW CLASS OF GAMMA DELTA T CELLS ACTIVATORS AND USE THEREOF | INNATE PHARMA (FR) | 2005-06-16 | — | — | WO | disclosed |
| EP-1328610-A4 | PHOSPHATE FLUOROSURFACTANTS FOR USE IN CARBON DIOXIDE | UNIV NORTH CAROLINA STATE (US) | 2004-09-01 | — | — | EP | disclosed |
| US-6684525-B2 | SURFACTANTS CONTAINING PHOSPHATE GROUP ATTACHED TO FLUOROHYDROCARABON, OR HYBRID WITH PHOSPHATE GROUP ATTACHED TO HYDROCARBON EXHIBIT SOLUBILITY IN CARBON DIOXIDE | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2004-02-03 | — | — | US | disclosed |
| EP-1328610-A1 | PHOSPHATE FLUOROSURFACTANTS FOR USE IN CARBON DIOXIDE | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2003-07-23 | — | — | EP | disclosed |
| WO-2002026921-A1 | PHOSPHATE FLUOROSURFACTANTS FOR USE IN CARBON DIOXIDE | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249565-A1 | Class of Gamma Delta T Cells Activators and Use Thereof | CD4, IFNG, NFATC1 | MMP1 4597/4885MMP3 3274/4885MMP8 988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.